Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
0.979
+0.009 (0.89%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Cardiol Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 109 | 105 | 54 | 32 | 112 | 72 | |
| Market Cap Growth | 9.43% | 93.06% | 67.34% | -71.06% | 56.56% | -21.55% | |
| Enterprise Value | 100 | 94 | 24 | -16 | 90 | 59 | |
| Last Close Price | 0.98 | 1.28 | 0.84 | 0.51 | 1.85 | 2.18 | |
| PS Ratio | - | - | - | - | 1803.25 | - | |
| PB Ratio | 15.84 | 6.11 | 2.54 | 0.84 | 1.86 | 6.88 | |
| P/TBV Ratio | 15.84 | 6.11 | 2.56 | 0.85 | 1.87 | 7.13 | |
| EV/Sales Ratio | - | - | - | - | 1441.08 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | |
| Net Debt / Equity Ratio | -1.20 | -1.23 | -1.23 | -1.14 | -1.10 | -1.04 | |
| Net Debt / EBITDA Ratio | 0.32 | 0.76 | 1.18 | 1.44 | 2.18 | 0.68 | |
| Net Debt / FCF Ratio | 0.47 | 1.21 | 1.38 | 2.18 | 3.56 | 1.51 | |
| Asset Turnover | - | - | - | - | 0.00 | - | |
| Quick Ratio | 3.59 | 4.41 | 4.25 | 6.12 | 7.29 | 5.66 | |
| Current Ratio | 3.89 | 4.52 | 4.36 | 6.27 | 7.54 | 5.94 | |
| Return on Equity (ROE) | -347.98% | -138.47% | -69.93% | -48.16% | -70.69% | -147.74% | |
| Return on Assets (ROA) | -148.83% | -73.43% | -37.71% | -34.47% | -46.58% | -82.38% | |
| Return on Capital Employed (ROCE) | -375.60% | -162.10% | -104.90% | -79.20% | -50.70% | -154.70% | |
| Earnings Yield | -22.96% | -24.30% | -39.19% | -70.37% | -22.28% | -22.60% | |
| FCF Yield | -16.41% | -16.61% | -35.17% | -62.10% | -16.58% | -10.04% | |
| Buyback Yield / Dilution | -21.91% | -11.02% | -3.13% | -44.61% | -44.77% | -15.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.